Kroger Specialty Pharmacy is proud to announce it is now dispensing CABENUVA (cabotegravir extended-release injectable suspension; rilpivirine extended-release injectable suspension) for treatment of HIV-1 infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL), on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
John King, SVP of Sales & Business Development for Kroger Specialty Pharmacy, recently shared what access to CABENUVA means for the HIV community. “Helping people live healthier lives is our mission at Kroger Specialty Pharmacy, and having the ability to support the HIV community with a complete portfolio of clinical offerings plays an important role in that mission. We are proud to add CABENUVA to our treatment options for patients living with this chronic disease.”
At Kroger Specialty Pharmacy our clinical and care teams have extensive experience with the treatment challenges that can arise when dealing with HIV and Hep C. We are passionate about simplifying the enrollment process for our patients by providing comprehensive financial services and personalized patient care support.
About Kroger Specialty Pharmacy:
At Kroger Specialty Pharmacy, our mission is to be the preferred pharmacy for people undergoing complex medication therapies by optimizing clinical outcomes and providing a high-touch, caring experience. As one of the nation's leading specialty pharmacies, Kroger Specialty Pharmacy offers comprehensive therapy-management programs as well as injectable and oral pharmaceutical treatments for Dermatology, HIV, Hepatitis C, Oncology, Multiple Sclerosis, Rheumatoid Arthritis, Growth Hormone Deficiency, Hunters Syndrome, Hemophilia, IVIG, HAE plus others. Kroger Specialty Pharmacy services patients in all 50 states and Puerto Rico and is ACHC and URAC Accredited in numerous sites. Kroger Specialty Pharmacy's clinically effective and cost-efficient therapy management programs provide direct value to healthcare organizations nationwide. We blend a high-touch, caring patient experience with specialized clinical knowledge, personalized care programs, and administrative expertise. For more information, visit www.krogerspecialtypharmacy.com.
About ViiV Healthcare:
ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for people living with HIV and for people who are at risk of becoming infected with HIV. Shionogi joined in October 2012. The company’s aim is to take a deeper and broader interest in HIV/AIDS than any company has done before and take a new approach to deliver effective and innovative medicines for HIV treatment and prevention, as well as support communities affected by HIV. For more information on the company, its management, portfolio, pipeline and commitment, please visit www.viivhealthcare.com.
Trade marks are owned by or licensed to the ViiV Healthcare group of companies. ©2021 ViiV Healthcare group of companies or its licensor.